Stay updated with breaking news from Nasdaq Amph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a research note issued to investors on Thursday morning. A number of other equities research analysts have also weighed in on AMPH. Piper Sandler raised their price objective on Amphastar Pharmaceuticals from $66.00 to $71.00 in […]
StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a report published on Thursday. A number of other equities analysts have also recently commented on the company. Piper Sandler raised their target price on Amphastar Pharmaceuticals from $66.00 to $71.00 in a report on Wednesday, […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) had its price target boosted by Piper Sandler from $55.00 to $66.00 in a report published on Tuesday, FlyOnTheWall reports. Separately, StockNews.com raised Amphastar Pharmaceuticals from a buy rating to a strong-buy rating in a report on Wednesday, June 21st. Amphastar Pharmaceuticals Price Performance AMPH stock opened at $61.62 […]
Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) reached a new 52-week high on Tuesday after Piper Sandler raised their price target on the stock from $55.00 to $66.00. The stock traded as high as $59.98 and last traded at $59.56, with a volume of 116364 shares changing hands. The stock had previously […]
StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) from a buy rating to a strong-buy rating in a research note issued to investors on Wednesday. Separately, Piper Sandler boosted their price target on Amphastar Pharmaceuticals from $43.00 to $55.00 in a research note on Thursday, June 15th. Amphastar Pharmaceuticals Stock Down 2.1 % […]